Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes
-
Published:2023-06-02
Issue:9
Volume:27
Page:1867-1875
-
ISSN:1091-255X
-
Container-title:Journal of Gastrointestinal Surgery
-
language:en
-
Short-container-title:J Gastrointest Surg
Author:
Lin Yuan-Mao, Fellman Bryan M., Taiji Ryosuke, Paolucci Iwan, Silva Jessica Albuquerque Marques, Koay Eugene J., Avritscher Rony, Mahvash Armeen, Holliday Emma B., Lee Sunyoung S., Kaseb Ahmed O., Das Prajnan, Vauthey Jean-Nicolas, Odisio Bruno C.ORCID
Subject
Gastroenterology,Surgery
Reference23 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi:https://doi.org/10.1002/ijc.29210. 2. Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv238-iv55. doi:https://doi.org/10.1093/annonc/mdy308. 3. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734-9. doi:https://doi.org/10.1016/s0140-6736(02)08649-x. 4. Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS et al. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol. 2016;34(5):460-8. doi:https://doi.org/10.1200/jco.2015.64.2710. 5. National Comprehensive Cancer Network. Hepatobiliary Cancer (Version 3.2021). 2021. https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|